Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Ventricular Mass as a Prognostic Imaging Biomarker in Incident PAH.

Simpson CE, Damico RL, Kolb TM, Mathai SC, Khair RM, Sato T, Bourji K, Tedford RJ, Zimmerman SL, Hassoun PM.

Eur Respir J. 2019 Jan 31. pii: 1802067. doi: 10.1183/13993003.02067-2018. [Epub ahead of print] No abstract available.

PMID:
30705128
2.

Disconnect between Fibrotic Response and Right Ventricular Dysfunction.

Crnkovic S, Egemnazarov B, Damico R, Marsh LM, Nagy BM, Douschan P, Atsina K, Kolb TM, Mathai SC, Hooper JE, Ghanim B, Klepetko W, Fruhwald F, Lassner D, Olschewski A, Olschewski H, Hassoun PM, Kwapiszewska G.

Am J Respir Crit Care Med. 2018 Dec 17. doi: 10.1164/rccm.201809-1737OC. [Epub ahead of print]

PMID:
30557518
3.

Discordance between Imaging Modalities in the Evaluation of Chronic Thromboembolic Pulmonary Hypertension: A Combined Experience from Two Academic Medical Centers.

Furfaro D, Azadi J, Housten T, Kolb TM, Damico RL, Hassoun PM, Chin K, Mathai SC.

Ann Am Thorac Soc. 2019 Feb;16(2):277-280. doi: 10.1513/AnnalsATS.201809-588RL. No abstract available.

PMID:
30359536
4.

Risk assessment in scleroderma patients with newly diagnosed pulmonary arterial hypertension: application of the ESC/ERS risk prediction model.

Mercurio V, Diab N, Peloquin G, Housten-Harris T, Damico R, Kolb TM, Mathai SC, Hassoun PM.

Eur Respir J. 2018 Oct 18;52(4). pii: 1800497. doi: 10.1183/13993003.00497-2018. Print 2018 Oct. No abstract available.

PMID:
30262575
5.

Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement.

Lahm T, Douglas IS, Archer SL, Bogaard HJ, Chesler NC, Haddad F, Hemnes AR, Kawut SM, Kline JA, Kolb TM, Mathai SC, Mercier O, Michelakis ED, Naeije R, Tuder RM, Ventetuolo CE, Vieillard-Baron A, Voelkel NF, Vonk-Noordegraaf A, Hassoun PM; American Thoracic Society Assembly on Pulmonary Circulation.

Am J Respir Crit Care Med. 2018 Aug 15;198(4):e15-e43. doi: 10.1164/rccm.201806-1160ST.

PMID:
30109950
6.

Supply and Demand: Micro(vascular) Economics of the Right Ventricle in Pulmonary Hypertension.

Kolb TM, Hassoun PM.

Am J Respir Cell Mol Biol. 2018 Oct;59(4):410-411. doi: 10.1165/rcmb.2018-0203ED. No abstract available.

PMID:
29995431
7.

Reply: Can treprostinil-induced early gastrointestinal side effects serve as predictors of pulmonary arterial hypertension prognosis?

Leary PJ, Kolb TM, Maron BA, Tedford RJ, Zamanian RT.

Int J Cardiol. 2018 Aug 1;264:188. doi: 10.1016/j.ijcard.2018.03.130. No abstract available.

PMID:
29776569
8.

Pulmonary Effective Arterial Elastance as a Measure of Right Ventricular Afterload and Its Prognostic Value in Pulmonary Hypertension Due to Left Heart Disease.

Tampakakis E, Shah SJ, Borlaug BA, Leary PJ, Patel HH, Miller WL, Kelemen BW, Houston BA, Kolb TM, Damico R, Mathai SC, Kasper EK, Hassoun PM, Kass DA, Tedford RJ.

Circ Heart Fail. 2018 Apr;11(4):e004436. doi: 10.1161/CIRCHEARTFAILURE.117.004436.

PMID:
29643065
9.

Pulmonary arterial hypertension and atrial arrhythmias: incidence, risk factors, and clinical impact.

Mercurio V, Peloquin G, Bourji KI, Diab N, Sato T, Enobun B, Housten-Harris T, Damico R, Kolb TM, Mathai SC, Tedford RJ, Tocchetti CG, Hassoun PM.

Pulm Circ. 2018 Apr-Jun;8(2):2045894018769874. doi: 10.1177/2045894018769874. Epub 2018 Mar 26.

10.

Focused Review of Perioperative Care of Patients with Pulmonary Hypertension and Proposal of a Perioperative Pathway.

Steppan J, Diaz-Rodriguez N, Barodka VM, Nyhan D, Pullins E, Housten T, Damico RL, Mathai SC, Hassoun PM, Berkowitz DE, Maxwell BG, Kolb TM.

Cureus. 2018 Jan 15;10(1):e2072. doi: 10.7759/cureus.2072. Review.

11.

Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium Report.

Elinoff JM, Agarwal R, Barnett CF, Benza RL, Cuttica MJ, Gharib AM, Gray MP, Hassoun PM, Hemnes AR, Humbert M, Kolb TM, Lahm T, Leopold JA, Mathai SC, McLaughlin VV, Preston IR, Rosenzweig EB, Shlobin OA, Steen VD, Zamanian RT, Solomon MA.

Am J Respir Crit Care Med. 2018 Jul 15;198(2):166-174. doi: 10.1164/rccm.201710-2093PP. No abstract available.

PMID:
29425462
12.

Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis-Associated Versus Idiopathic Pulmonary Arterial Hypertension.

Hsu S, Kokkonen-Simon KM, Kirk JA, Kolb TM, Damico RL, Mathai SC, Mukherjee M, Shah AA, Wigley FM, Margulies KB, Hassoun PM, Halushka MK, Tedford RJ, Kass DA.

Circulation. 2018 May 29;137(22):2360-2370. doi: 10.1161/CIRCULATIONAHA.117.033147. Epub 2018 Jan 19.

PMID:
29352073
13.

The impact of ambrisentan and tadalafil upfront combination therapy on cardiac function in scleroderma associated pulmonary arterial hypertension patients: cardiac magnetic resonance feature tracking study.

Sato T, Ambale-Venkatesh B, Lima JAC, Zimmerman SL, Tedford RJ, Fujii T, Hulme OL, Pullins EH, Corona-Villalobos CP, Zamanian RT, Minai OA, Girgis RE, Chin K, Khair R, Damico RL, Kolb TM, Mathai SC, Hassoun PM.

Pulm Circ. 2018 Jan-Mar;8(1):2045893217748307. doi: 10.1177/2045893217748307. Epub 2017 Dec 18.

PMID:
29251556
14.

Right ventricular longitudinal strain is diminished in systemic sclerosis compared with idiopathic pulmonary arterial hypertension.

Mukherjee M, Mercurio V, Tedford RJ, Shah AA, Hsu S, Mullin CJ, Sato T, Damico R, Kolb TM, Mathai SC, Hassoun PM.

Eur Respir J. 2017 Nov 22;50(5). pii: 1701436. doi: 10.1183/13993003.01436-2017. Print 2017 Nov. No abstract available.

15.

Evaluation of criteria for exercise-induced pulmonary hypertension in patients with resting pulmonary hypertension.

Mullin CJ, Hsu S, Amancherla K, Wand A, Rhodes P, Leary PJ, Mukherjee M, Damico RL, Kolb TM, Mathai SC, Hassoun PM, Tedford RJ.

Eur Respir J. 2017 Sep 20;50(3). pii: 1700784. doi: 10.1183/13993003.00784-2017. Print 2017 Sep. No abstract available.

16.

XOR inhibition with febuxostat accelerates pulmonary endothelial barrier recovery and improves survival in lipopolysaccharide-induced murine sepsis.

Damarla M, Johnston LF, Liu G, Gao L, Wang L, Varela L, Kolb TM, Kim BS, Damico RL, Hassoun PM.

Physiol Rep. 2017 Aug;5(15). pii: e13377. doi: 10.14814/phy2.13377.

17.

Use of thermodilution cardiac output overestimates diagnoses of exercise-induced pulmonary hypertension.

Hsu S, Brusca SB, Rhodes PS, Kolb TM, Mathai SC, Tedford RJ.

Pulm Circ. 2017 Jan 1;7(1):253-255. doi: 10.1086/690629. eCollection 2017 Mar.

18.

Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.

Mercurio V, Mukherjee M, Tedford RJ, Zamanian RT, Khair RM, Sato T, Minai OA, Torres F, Girgis RE, Chin K, Damico R, Kolb TM, Mathai SC, Hassoun PM.

Am J Respir Crit Care Med. 2018 Feb 1;197(3):388-391. doi: 10.1164/rccm.201704-0789LE. No abstract available.

19.

Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction.

Bourji KI, Kelemen BW, Mathai SC, Damico RL, Kolb TM, Mercurio V, Cozzi F, Tedford RJ, Hassoun PM.

Pulm Circ. 2017 Apr-Jun;7(2):409-420. doi: 10.1177/2045893217700438. Epub 2017 Mar 27.

20.

What's in a side effect? The association between pulmonary vasodilator adverse drug events and clinical outcomes in patients with pulmonary arterial hypertension.

Leary PJ, Kang S, Kolb TM, Maron BA, Ralph DD, Rao Y, Tedford RJ, Zamanian RT.

Int J Cardiol. 2017 Aug 1;240:386-391. doi: 10.1016/j.ijcard.2017.04.016. Epub 2017 Apr 6.

PMID:
28412029
21.

Pulmonary Arterial Compliance in Acute Respiratory Distress Syndrome: Clinical Determinants and Association With Outcome From the Fluid and Catheter Treatment Trial Cohort.

Metkus TS, Tampakakis E, Mullin CJ, Houston BA, Kolb TM, Mathai SC, Damico R, Maron BA, Hassoun PM, Brower RG, Tedford RJ.

Crit Care Med. 2017 Mar;45(3):422-429. doi: 10.1097/CCM.0000000000002186.

22.

Heart Rate Dependence of the Pulmonary Resistance x Compliance (RC) Time and Impact on Right Ventricular Load.

Metkus TS, Mullin CJ, Grandin EW, Rame JE, Tampakakis E, Hsu S, Kolb TM, Damico R, Hassoun PM, Kass DA, Mathai SC, Tedford RJ.

PLoS One. 2016 Nov 18;11(11):e0166463. doi: 10.1371/journal.pone.0166463. eCollection 2016.

23.

Bronchus-associated Lymphoid Tissue in Kabuki Syndrome with Associated Hyper-IgM Syndrome/Common Variable Immunodeficiency.

Mock JR, Kolb TM, Illei PB, Yang SC, Lederman HM, Merlo CA.

Am J Respir Crit Care Med. 2016 Aug 15;194(4):514-5. doi: 10.1164/rccm.201511-2305IM. No abstract available.

24.

Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension.

Hsu S, Houston BA, Tampakakis E, Bacher AC, Rhodes PS, Mathai SC, Damico RL, Kolb TM, Hummers LK, Shah AA, McMahan Z, Corona-Villalobos CP, Zimmerman SL, Wigley FM, Hassoun PM, Kass DA, Tedford RJ.

Circulation. 2016 Jun 14;133(24):2413-22. doi: 10.1161/CIRCULATIONAHA.116.022082. Epub 2016 May 11.

25.

Health-related Quality of Life and Survival in Pulmonary Arterial Hypertension.

Mathai SC, Suber T, Khair RM, Kolb TM, Damico RL, Hassoun PM.

Ann Am Thorac Soc. 2016 Jan;13(1):31-9. doi: 10.1513/AnnalsATS.201412-572OC.

26.

Bidimensional measurements of right ventricular function for prediction of survival in patients with pulmonary hypertension: comparison of reproducibility and time of analysis with volumetric cardiac magnetic resonance imaging analysis.

Corona-Villalobos CP, Kamel IR, Rastegar N, Damico R, Kolb TM, Boyce DM, Sager AE, Skrok J, Shehata ML, Vogel-Claussen J, Bluemke DA, Girgis RE, Mathai SC, Hassoun PM, Zimmerman SL.

Pulm Circ. 2015 Sep;5(3):527-37. doi: 10.1086/682229.

27.

Macrophage Migration Inhibitory Factor: A Novel Inhibitor of Apoptosis Signal-Regulating Kinase 1-p38-Xanthine Oxidoreductase-Dependent Cigarette Smoke-Induced Apoptosis.

Fallica J, Varela L, Johnston L, Kim B, Serebreni L, Wang L, Damarla M, Kolb TM, Hassoun PM, Damico R.

Am J Respir Cell Mol Biol. 2016 Apr;54(4):504-14. doi: 10.1165/rcmb.2014-0403OC.

28.

Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.

Hassoun PM, Zamanian RT, Damico R, Lechtzin N, Khair R, Kolb TM, Tedford RJ, Hulme OL, Housten T, Pisanello C, Sato T, Pullins EH, Corona-Villalobos CP, Zimmerman SL, Gashouta MA, Minai OA, Torres F, Girgis RE, Chin K, Mathai SC.

Am J Respir Crit Care Med. 2015 Nov 1;192(9):1102-10. doi: 10.1164/rccm.201507-1398OC.

29.

Right Ventricular Angiogenesis is an Early Adaptive Response to Chronic Hypoxia-Induced Pulmonary Hypertension.

Kolb TM, Peabody J, Baddoura P, Fallica J, Mock JR, Singer BD, D'Alessio FR, Damarla M, Damico RL, Hassoun PM.

Microcirculation. 2015 Nov;22(8):724-36. doi: 10.1111/micc.12247.

30.

Right ventricular remodeling in idiopathic and scleroderma-associated pulmonary arterial hypertension: two distinct phenotypes.

Kelemen BW, Mathai SC, Tedford RJ, Damico RL, Corona-Villalobos C, Kolb TM, Chaisson NF, Harris TH, Zimmerman SL, Kamel IR, Kass DA, Hassoun PM.

Pulm Circ. 2015 Jun;5(2):327-34. doi: 10.1086/680356.

31.

Association between serum concentrations of hypoxia inducible factor responsive proteins and excessive erythrocytosis in high altitude Peru.

Painschab MS, Malpartida GE, Dávila-Roman VG, Gilman RH, Kolb TM, León-Velarde F, Miranda JJ, Checkley W.

High Alt Med Biol. 2015 Mar;16(1):26-33. doi: 10.1089/ham.2014.1086. Epub 2015 Mar 11.

32.

Vascular receptor autoantibodies in pulmonary arterial hypertension.

Bourji KI, Khair RM, Damico RL, Kolb TM, Mathai SC, Hassoun PM.

Am J Respir Crit Care Med. 2015 Mar 1;191(5):602. doi: 10.1164/rccm.201412-2267LE. No abstract available.

PMID:
25723828
33.

Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension.

Damico R, Kolb TM, Valera L, Wang L, Housten T, Tedford RJ, Kass DA, Rafaels N, Gao L, Barnes KC, Benza RL, Rand JL, Hamid R, Loyd JE, Robbins IM, Hemnes AR, Chung WK, Austin ED, Drummond MB, Mathai SC, Hassoun PM.

Am J Respir Crit Care Med. 2015 Jan 15;191(2):208-18. doi: 10.1164/rccm.201409-1742OC.

34.

Severity of systemic sclerosis-associated pulmonary arterial hypertension in African Americans.

Blanco I, Mathai S, Shafiq M, Boyce D, Kolb TM, Chami H, Hummers LK, Housten T, Chaisson N, Zaiman AL, Wigley FM, Tedford RJ, Kass DA, Damico R, Girgis RE, Hassoun PM.

Medicine (Baltimore). 2014 Jul;93(5):177-85. doi: 10.1097/MD.0000000000000032.

35.

Macrophage migration inhibitory factor is a novel determinant of cigarette smoke-induced lung damage.

Fallica J, Boyer L, Kim B, Serebreni L, Varela L, Hamdan O, Wang L, Simms T, Damarla M, Kolb TM, Bucala R, Mitzner W, Hassoun PM, Damico R.

Am J Respir Cell Mol Biol. 2014 Jul;51(1):94-103. doi: 10.1165/rcmb.2013-0371OC.

36.

Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension.

Tedford RJ, Beaty CA, Mathai SC, Kolb TM, Damico R, Hassoun PM, Leary PJ, Kass DA, Shah AS.

J Heart Lung Transplant. 2014 Mar;33(3):289-97. doi: 10.1016/j.healun.2013.11.008. Epub 2013 Nov 28. Erratum in: J Heart Lung Transplant. 2019 Feb;38(2):233.

37.

Protein kinase G increases antioxidant function in lung microvascular endothelial cells by inhibiting the c-Abl tyrosine kinase.

Stephens RS, Servinsky LE, Rentsendorj O, Kolb TM, Pfeifer A, Pearse DB.

Am J Physiol Cell Physiol. 2014 Mar 15;306(6):C559-69. doi: 10.1152/ajpcell.00375.2012. Epub 2014 Jan 8.

38.

Mitogen-activated protein kinase-activated protein kinase 2 mediates apoptosis during lung vascular permeability by regulating movement of cleaved caspase 3.

Damarla M, Parniani AR, Johnston L, Maredia H, Serebreni L, Hamdan O, Sidhaye VK, Shimoda LA, Myers AC, Crow MT, Schmidt EP, Machamer CE, Gaestel M, Rane MJ, Kolb TM, Kim BS, Damico RL, Hassoun PM.

Am J Respir Cell Mol Biol. 2014 May;50(5):932-41. doi: 10.1165/rcmb.2013-0361OC.

39.

A 32-year-old woman with dyspnea, lung cysts, and previous pneumothoraces.

Kolb TM, King LS, Pearse DB.

Chest. 2013 Dec;144(6):1964-1968. doi: 10.1378/chest.13-0902. No abstract available.

PMID:
24297131
40.

Right ventricular dysfunction in chronic lung disease.

Kolb TM, Hassoun PM.

Cardiol Clin. 2012 May;30(2):243-56. doi: 10.1016/j.ccl.2012.03.005. Review.

41.

Linking new and old concepts: inflammation meets the Warburg phenomenon in pulmonary arterial hypertension.

Kolb TM, Damico RL, Hassoun PM.

J Mol Med (Berl). 2011 Aug;89(8):729-32. doi: 10.1007/s00109-011-0783-x. No abstract available.

PMID:
21735043
42.

Tsc2 expression increases the susceptibility of renal tumor cells to apoptosis.

Kolb TM, Duan L, Davis MA.

Toxicol Sci. 2005 Dec;88(2):331-9. Epub 2005 Sep 8.

PMID:
16150885
45.

Biochemical and morphological events during okadaic acid-induced apoptosis of Tsc2-null ERC-18 cell line.

Kolb TM, Chang SH, Davis MA.

Toxicol Pathol. 2002 Mar-Apr;30(2):235-46.

PMID:
11950167
46.

Sequential acquisition of toilet-training skills: a descriptive study of gender and age differences in normal children.

Schum TR, Kolb TM, McAuliffe TL, Simms MD, Underhill RL, Lewis M.

Pediatrics. 2002 Mar;109(3):E48.

PMID:
11875176
47.

Ultrasound boosts cancer detection in dense breasts.

Kolb TM.

Diagn Imaging (San Franc). 2000 Nov;22(11):103-4, 107-11. No abstract available.

PMID:
11148953
48.

Supplemental Content

Support Center